168 related articles for article (PubMed ID: 36835228)
1. The Cannabinoid Ligand Arachidonyl-2'-Chloroethylamide (ACEA) Ameliorates Depressive and Overactive Bladder Symptoms in a Corticosterone-Induced Female Wistar Rat Model.
Zapała Ł; Niemczyk G; Zapała P; Wdowiak A; Bojar I; Kluz T; Szopa A; Serefko A; Radziszewski P; Wróbel A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835228
[TBL] [Abstract][Full Text] [Related]
2. [Cannabinoid receptor 1 agonist arachidonyl-2'-chloroethylamide (ACEA) improves sepsis-associated encephalopathy by inhibiting inflammatory factors].
Yang Z; Wu Y; Tang J; Liu R; Fang Z; Su B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Apr; 40(4):319-326. PubMed ID: 38710516
[TBL] [Abstract][Full Text] [Related]
3. Arachidonyl-2'-chloroethylamide (ACEA), a synthetic agonist of cannabinoid receptor, increases CB
Leija-Salazar M; Bermúdez de León M; González-Horta A; González-Hernández B
Pharmacol Biochem Behav; 2020 Jul; 194():172950. PubMed ID: 32413434
[TBL] [Abstract][Full Text] [Related]
4. Effects of the cannabinoid CB
Berger JI; Coomber B; Hill S; Alexander SPH; Owen W; Palmer AR; Wallace MN
Hear Res; 2017 Dec; 356():51-62. PubMed ID: 29108871
[TBL] [Abstract][Full Text] [Related]
5. Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats.
Kim SD; Cho KJ; Kim JC
BMC Urol; 2017 Dec; 17(1):121. PubMed ID: 29284441
[TBL] [Abstract][Full Text] [Related]
6. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ
Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590
[TBL] [Abstract][Full Text] [Related]
7. Effect of ACEA--a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.
Andres-Mach M; Zolkowska D; Barcicka-Klosowska B; Haratym-Maj A; Florek-Luszczki M; Luszczki JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):301-9. PubMed ID: 22789660
[TBL] [Abstract][Full Text] [Related]
8. The interaction between ghrelin and cannabinoid systems in penicillin-induced epileptiform activity in rats.
Arslan G; Ayyildiz M; Agar E
Neuropeptides; 2014 Dec; 48(6):345-52. PubMed ID: 25256087
[TBL] [Abstract][Full Text] [Related]
9. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
[TBL] [Abstract][Full Text] [Related]
10. The cannabinomimetic arachidonyl-2-chloroethylamide (ACEA) acts on capsaicin-sensitive TRPV1 receptors but not cannabinoid receptors in rat joints.
Baker CL; McDougall JJ
Br J Pharmacol; 2004 Aug; 142(8):1361-7. PubMed ID: 15277316
[TBL] [Abstract][Full Text] [Related]
11. Dual action of the cannabinoid receptor 1 ligand arachidonyl-2'-chloroethylamide on calcitonin gene-related peptide release.
Christiansen IM; Edvinsson JCA; Reducha PV; Edvinsson L; Haanes KA
J Headache Pain; 2022 Feb; 23(1):30. PubMed ID: 35189809
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Rho kinase by GSK 269962 reverses both corticosterone-induced detrusor overactivity and depression-like behaviour in rats.
Wróbel A; Serefko A; Rechberger E; Banczerowska-Górska M; Poleszak E; Dudka J; Skorupska K; Miotła P; Semczuk A; Kulik-Rechberger B; Mandziuk S; Rechberger T
Eur J Pharmacol; 2018 Oct; 837():127-136. PubMed ID: 30172788
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant--like properties of ACEA (arachidonyl-2-chloroethylamide), the selective agonist of CB1 receptors.
Rutkowska M; Jachimczuk O
Acta Pol Pharm; 2004; 61(2):165-7. PubMed ID: 15493300
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid Receptor Type 1 Agonist ACEA Improves Cognitive Deficit on STZ-Induced Neurotoxicity Through Apoptosis Pathway and NO Modulation.
Crunfli F; Vrechi TA; Costa AP; Torrão AS
Neurotox Res; 2019 Apr; 35(3):516-529. PubMed ID: 30607903
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis.
Tambaro S; Casu MA; Mastinu A; Lazzari P
Eur J Pharmacol; 2014 Apr; 729():67-74. PubMed ID: 24561047
[TBL] [Abstract][Full Text] [Related]
16. Influence of arachidonyl-2'-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the anticonvulsant and acute side-effect potentials of clobazam, lacosamide, and pregabalin in the maximal electroshock-induced seizure model and chimney test in mice.
Florek-Luszczki M; Zagaja M; Luszczki JJ
Fundam Clin Pharmacol; 2015 Aug; 29(4):382-93. PubMed ID: 25904357
[TBL] [Abstract][Full Text] [Related]
17. Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons.
Wang ZY; McDowell T; Wang P; Alvarez R; Gomez T; Bjorling DE
Neuroscience; 2014 Sep; 277():679-89. PubMed ID: 25088915
[TBL] [Abstract][Full Text] [Related]
18. Activation of the cannabinoid receptor 1 by ACEA suppresses senescence in human primary chondrocytes through sirt1 activation.
Zhang D; Zhang G; Li Z; Li B
Exp Biol Med (Maywood); 2018 Mar; 243(5):437-443. PubMed ID: 29444596
[TBL] [Abstract][Full Text] [Related]
19. Blebbistatin, a Myosin II Inhibitor, Exerts Antidepressant-Like Activity and Suppresses Detrusor Overactivity in an Animal Model of Depression Coexisting with Overactive Bladder.
Wróbel A; Doboszewska U; Rechberger E; Bańczerowska-Górska M; Czuczwar P; Poleszak E; Dudka J; Wlaź P; Miotła P; Wlaźlak E; Rechberger T
Neurotox Res; 2019 Jan; 35(1):196-207. PubMed ID: 30155683
[TBL] [Abstract][Full Text] [Related]
20. A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors.
Wróbel A; Szopa A; Serefko A; Poleszak E
Molecules; 2020 Mar; 25(6):. PubMed ID: 32197469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
